Updated Jul 16, 2026
Hodgson Ian is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market sales: $26K.

Ian Hodgson is listed as the Chief Operating Officer of Corbus Pharmaceuticals Holdings, Inc. (CRBP) in the most recent SEC filing dated January 16, 2026. The filing shows Hodgson in the COO role with no reported stock purchases or sales, indicating a straightforward insider profile for that period.
| Role | Insider |
|---|---|
| Notability | 40/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-02-18 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | S — Open-market sale | 847 | $7.38 | $6K |
| 2026-02-04 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | S — Open-market sale | 2.4K | $8.09 | $20K |
| 2026-01-16 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | A — Grant or award | 28.4K | $0.00 |
Ian Hodgson is listed as the Chief Operating Officer of Corbus Pharmaceuticals Holdings, Inc. (CRBP) in the most recent SEC filing dated January 16, 2026. The filing shows Hodgson in the COO role with no reported stock purchases or sales, indicating a straightforward insider profile for that period.…
Recorded transactions: 0 open-market purchases () and 2 open-market sales ($26K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Hodgson Ian profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.